- Report
- November 2022
- 129 Pages
Asia Pacific
From €3076EUR$3,450USD£2,643GBP
- Report
- November 2023
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- August 2024
Europe, United States, ... Europe, United States, Japan
From €3120EUR$3,500USD£2,682GBP
- Report
- November 2024
- 150 Pages
Global
From €4324EUR$4,850USD£3,716GBP
- Report
- August 2023
- 95 Pages
Global
From €3500EUR$4,205USD£3,113GBP
- Report
- September 2025
Global
From €3120EUR$3,500USD£2,682GBP
- Report
- November 2024
United States, Europe, ... United States, Europe, Japan
From €1337EUR$1,500USD£1,149GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4012EUR$4,500USD£3,448GBP
- Report
- October 2024
Global
From €3120EUR$3,500USD£2,682GBP
The Helicobacter Pylori Test is a diagnostic test used to detect the presence of the Helicobacter pylori bacteria in the stomach. This bacteria is associated with a number of gastrointestinal diseases, including gastritis, peptic ulcer disease, and gastric cancer. The test is used to diagnose and monitor the effectiveness of treatment for these conditions. The test is typically performed using a blood sample, stool sample, or breath test.
The Helicobacter Pylori Test market is a subset of the larger Infectious Disease Testing market. This market is driven by the increasing prevalence of infectious diseases, the need for accurate and timely diagnosis, and the development of new technologies.
Some companies in the Helicobacter Pylori Test market include Abbott Laboratories, Becton Dickinson, Cepheid, DiaSorin, and Hologic. Show Less Read more